Alector (ALEC) Debt Ratio (2024 - 2026)

Alector (ALEC) reported Debt Ratio of 0.04 for Q1 2026, up 75.63% year-over-year from 0.02 in Q1 2025, and up 23.21% quarter-over-quarter from 0.03 in Q4 2025.

Alector (ALEC) Debt Ratio (2024 - 2026) Analysis & Trends

Alector (ALEC) has 3 years of Debt Ratio data on file, last reported at 0.04 in Q1 2026.

  • Debt Ratio for Q1 2026 came in at 0.04, up 75.63% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.04 (up 75.63% YoY), and the FY2025 annual result was 0.03, up 64.8% from the prior year.
  • Debt Ratio climbed to 0.04 in Q1 2026 per ALEC's latest filing, from 0.03 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.04 in Q1 2026 and troughed at 0.02 in Q4 2024.
  • A 3-year average of 0.03 and a median of 0.03 in 2025 frame the typical range for Debt Ratio.
  • The sharpest annual moves came in 2025 and 2026: Debt Ratio jumped 64.8% in 2025, then soared 75.63% in 2026.
  • A 3-year view of Debt Ratio shows it stood at 0.02 in 2024, then soared by 64.8% to 0.03 in 2025, then rose by 23.21% to 0.04 in 2026.
  • Business Quant data shows ALEC's Debt Ratio at 0.04 in Q1 2026, 0.03 in Q4 2025, and 0.03 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.18
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Alector 193.53 Mn -12.98 Mn - 0.04

Historic Data

Download Data
DateValue
Mar 31, 2026 0.04
Dec 31, 2025 0.03
Sep 30, 2025 0.03
Jun 30, 2025 0.03
Mar 31, 2025 0.02
Dec 31, 2024 0.02